NXNL1 and retinitis pigmentosa 1: In vitro administration of glucose or RdCVF in cones delayed their loss of function during RP progression [11,38], and injection of RdCVF in animal models of RP prevents the shortening of cone outer segments, which precedes cone loss [3,39].